Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1994 4
1995 7
1996 8
1997 24
1998 25
1999 29
2000 40
2001 37
2002 51
2003 40
2004 68
2005 84
2006 81
2007 106
2008 105
2009 111
2010 102
2011 101
2012 99
2013 99
2014 103
2015 98
2016 86
2017 76
2018 91
2019 97
2020 114
2021 100
2022 85
2023 69
2024 91
2025 40

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,012 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia.
Zhou Y, Yu S, Zhao J, Feng X, Zhang M, Zhao Z. Zhou Y, et al. Biomed Res Int. 2020 Aug 4;2020:1501893. doi: 10.1155/2020/1501893. eCollection 2020. Biomed Res Int. 2020. PMID: 32802833 Free PMC article. Clinical Trial.
Therefore, the present study is aimed at investigating the efficacy and safety of botulinum toxin type A (BTA) in patients with AGA. METHODS: 63 patients with AGA meeting the inclusion criteria were included in this study and treated with BTA injection …
Therefore, the present study is aimed at investigating the efficacy and safety of botulinum toxin type A (BTA) i …
Trial of Botulinum Toxin for Isolated or Essential Head Tremor.
Marques A, Pereira B, Simonetta-Moreau M, Castelnovo G, De Verdal M, Fluchère F, Laurencin C, Degos B, Tir M, Kreisler A, Blanchet-Fourcade G, Guehl D, Colin O, Poujois A, Sangla S, Tatu L, Derost P, Gayraud D, Tranchant C, Amarantini D, Devos D, Rascol O, Corvol JC, Durif F, Rieu I; Btx-HT Study Group. Marques A, et al. N Engl J Med. 2023 Nov 9;389(19):1753-1765. doi: 10.1056/NEJMoa2304192. N Engl J Med. 2023. PMID: 37937777 Clinical Trial.
BACKGROUND: Local injections of botulinum toxin type A have been used to treat essential head tremor but have not been extensively studied in randomized trials. METHODS: In a multicenter, double-blind, randomized trial, we assigned, in a 1:1 ratio, adu …
BACKGROUND: Local injections of botulinum toxin type A have been used to treat essential head tremor but have no …
Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation.
Piccini JP, Ahlsson A, Dorian P, Gillinov AM, Kowey PR, Mack MJ, Milano CA, Noiseux N, Perrault LP, Ryan W, Steinberg JS, Voisine P, Waldron NH, Gleason KJ, Titanji W, Leaback RD, O'Sullivan A, Ferguson WG, Benussi S; NOVA-AF Investigators. Piccini JP, et al. JACC Clin Electrophysiol. 2024 May;10(5):930-940. doi: 10.1016/j.jacep.2024.01.020. Epub 2024 Apr 24. JACC Clin Electrophysiol. 2024. PMID: 38661602 Free article. Clinical Trial.
These hypothesis-generating findings require investigation in a larger, adequately powered randomized clinical trial. (Botulinum Toxin Type A [AGN-151607] for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-ch …
These hypothesis-generating findings require investigation in a larger, adequately powered randomized clinical trial. (Botulinum T
Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
Jadhao VA, Lokhande N, Habbu SG, Sewane S, Dongare S, Goyal N. Jadhao VA, et al. Indian J Dent Res. 2017 Sep-Oct;28(5):493-497. doi: 10.4103/ijdr.IJDR_125_17. Indian J Dent Res. 2017. PMID: 29072209 Free article. Clinical Trial.
AIM AND OBJECTIVE: The present study was conducted in patients with bruxism to evaluate the effect of botulinum toxin type A (BTX-A) (Botox, Allergan, Inc., Irvine, CA, USA) in the treatment of myofascial pain and the occlusal force characteristics of …
AIM AND OBJECTIVE: The present study was conducted in patients with bruxism to evaluate the effect of botulinum toxin type
Assessing the efficacy and quality of Life improvements of botulinum toxin type a with topical minoxidil versus topical minoxidil in male androgenetic alopecia: a randomized controlled trial.
Yu L, Moorthy S, Li X, Peng L, Zhang Z, Shen L, Han Y, Huang X. Yu L, et al. Arch Dermatol Res. 2024 Aug 17;316(8):532. doi: 10.1007/s00403-024-03258-9. Arch Dermatol Res. 2024. PMID: 39154106 Clinical Trial.
Therefore, the present study aimed to investigate the efficacy and safety of botulinum toxin type A (BTA) combined with Minoxidil in patients with AGA. 60 male patients were included in this study and control group received topical 5% Minoxidil and the …
Therefore, the present study aimed to investigate the efficacy and safety of botulinum toxin type A (BTA) combin …
Botulinum toxin type A and acupuncture for masticatory myofascial pain: a randomized clinical trial.
DE LA Torre Canales G, Câmara-Souza MB, Poluha RL, Grillo CM, Conti PCR, Sousa MDLR, Rodrigues Garcia RCM, Rizzatti-Barbosa CM. DE LA Torre Canales G, et al. J Appl Oral Sci. 2021 Jun 4;29:e20201035. doi: 10.1590/1678-7757-2020-1035. eCollection 2021. J Appl Oral Sci. 2021. PMID: 34105695 Free PMC article. Clinical Trial.
OBJECTIVE: this study aimed to compare the immediate effects of botulinum toxin type A (BoNT-A) injections and Acupuncture in myofascial temporomandibular disorders (TMD) patients. ...
OBJECTIVE: this study aimed to compare the immediate effects of botulinum toxin type A (BoNT-A) injections and A …
A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians.
Choi SY, Koh YG, Lee YW, Son HS, Yoon YN, Kim G, Won C, Cho H, Son JS, Kim EK, Kim BJ. Choi SY, et al. J Dermatolog Treat. 2024 Dec;35(1):2359511. doi: 10.1080/09546634.2024.2359511. Epub 2024 Jun 16. J Dermatolog Treat. 2024. PMID: 38880494 Free article. Clinical Trial.
Botulinum toxin type A (BoNT-A) was first isolated in 1946, and since then, several formulations have been developed and widely used to treat wrinkles by inducing muscle paralysis. ...
Botulinum toxin type A (BoNT-A) was first isolated in 1946, and since then, several formulations have been devel
2,012 results